Leavitt Chase C.
Related Filers (2)
Ownership (18)
4
Thursday, 2/15/2024
Oncternal Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Friday, 1/5/2024
Oncternal Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Wednesday, 10/4/2023
Oncternal Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Wednesday, 7/5/2023
Oncternal Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Friday, 4/14/2023
Oncternal Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Thursday, 2/23/2023
Oncternal Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Thursday, 1/5/2023
Oncternal Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Monday, 8/1/2022
Oncternal Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Monday, 1/31/2022
Oncternal Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Monday, 1/24/2022
Oncternal Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Wednesday, 1/5/2022
Oncternal Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Tuesday, 6/15/2021
Oncternal Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
3
Thursday, 5/27/2021
Oncternal Therapeutics, Inc.: Initial statement of beneficial ownership of securities
4
Wednesday, 3/17/2021
Lineage Cell Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Thursday, 3/19/2020
Lineage Cell Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Thursday, 8/15/2019
Lineage Cell Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Wednesday, 5/22/2019
BIOTIME INC: Statement of changes in beneficial ownership of securities
3
Wednesday, 5/22/2019
BIOTIME INC: Initial statement of beneficial ownership of securities